Fresenius Medical Care AG (FMS) Income towards Parent Company (2009 - 2026)

Fresenius Medical Care AG's Income towards Parent Company history runs 18 years deep, the most recent figure standing at $137.6 million for Q1 2026.

• In Q1 2026, Income towards Parent Company fell 13.5% year-over-year to $137.6 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 64.33% YoY), while the FY2025 annual figure was $1.1 billion, up 98.02% from the prior year.
• Income towards Parent Company for Q1 2026 stood at $137.6 million, down from $380.6 million in the prior quarter.
• The five-year high for Income towards Parent Company was $380.6 million in Q4 2025, with the low at $71.6 million in Q4 2024.
• The 5-year median for Income towards Parent Company is $176.6 million (2022), against an average of $195.3 million.
• The sharpest annual moves came in 2024 and 2025: Income towards Parent Company sank 56.79% in 2024, then soared 431.65% in 2025.
• Fresenius Medical Care AG's Income towards Parent Company stood at $258.1 million in 2022, then tumbled by 35.81% to $165.7 million in 2023, then tumbled by 56.79% to $71.6 million in 2024, then jumped by 431.65% to $380.6 million in 2025, then slumped by 63.85% to $137.6 million in 2026.
• Business Quant data shows FMS's Income towards Parent Company at $137.6 million in Q1 2026, $380.6 million in Q4 2025, and $321.3 million in Q3 2025.